These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28351888)

  • 1. Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency.
    Gomaraschi M; Ossoli A; Castelnuovo S; Simonelli S; Pavanello C; Balzarotti G; Arca M; Di Costanzo A; Sampietro T; Vaudo G; Baldassarre D; Veglia F; Franceschini G; Calabresi L
    J Lipid Res; 2017 May; 58(5):994-1001. PubMed ID: 28351888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
    Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L
    J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency.
    Tilly-Kiesi M; Zhang Q; Ehnholm S; Kahri J; Lahdenperä S; Ehnholm C; Taskinen MR
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1294-306. PubMed ID: 7670941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of LCAT in HDL remodeling: investigation of LCAT deficiency states.
    Asztalos BF; Schaefer EJ; Horvath KV; Yamashita S; Miller M; Franceschini G; Calabresi L
    J Lipid Res; 2007 Mar; 48(3):592-9. PubMed ID: 17183024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of subspecies of apolipoprotein A-I-containing lipoprotein in homozygotes for familial lecithin:cholesterol acyltransferase deficiency.
    Ohta T; Hattori S; Nakamura R; Horiuchi S; Frohlich J; Takata K; Ikeda Y; Saito Y; Matsuda I
    Arterioscler Thromb; 1994 Jul; 14(7):1137-45. PubMed ID: 8018670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein X Causes Renal Disease in LCAT Deficiency.
    Ossoli A; Neufeld EB; Thacker SG; Vaisman B; Pryor M; Freeman LA; Brantner CA; Baranova I; Francone NO; Demosky SJ; Vitali C; Locatelli M; Abbate M; Zoja C; Franceschini G; Calabresi L; Remaley AT
    PLoS One; 2016; 11(2):e0150083. PubMed ID: 26919698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal vascular function despite low levels of high-density lipoprotein cholesterol in carriers of the apolipoprotein A-I(Milano) mutant.
    Gomaraschi M; Baldassarre D; Amato M; Eligini S; Conca P; Sirtori CR; Franceschini G; Calabresi L
    Circulation; 2007 Nov; 116(19):2165-72. PubMed ID: 17967773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I.
    Ng DS; Francone OL; Forte TM; Zhang J; Haghpassand M; Rubin EM
    J Biol Chem; 1997 Jun; 272(25):15777-81. PubMed ID: 9188474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of apolipoprotein A1- or lecithin:cholesterol acyltransferase-deficiency on white adipose tissue metabolic activity and glucose homeostasis in mice.
    Xepapadaki E; Maulucci G; Constantinou C; Karavia EA; Zvintzou E; Daniel B; Sasson S; Kypreos KE
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1351-1360. PubMed ID: 30742993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of spherical, reconstituted high density lipoproteins containing both apolipoproteins A-I and A-II is mediated by lecithin:cholesterol acyltransferase.
    Clay MA; Pyle DH; Rye KA; Barter PJ
    J Biol Chem; 2000 Mar; 275(12):9019-25. PubMed ID: 10722751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for impaired cellular cholesterol removal mediated by apo A-I containing lipoproteins in patients with familial lecithin: cholesterol acyltransferase deficiency.
    Ohta T; Nakamura R; Ikeda Y; Frohlich J; Takata K; Saito Y; Horiuchi S; Matsuda I
    Biochim Biophys Acta; 1994 Aug; 1213(3):295-301. PubMed ID: 8049242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of subspecies of lipoprotein containing apolipoprotein A-I in heterozygotes for familial lecithin:cholesterol acyltransferase deficiency.
    Ohta T; Nakamura R; Frohlich JJ; Pritchard PH; Matsuda I
    Atherosclerosis; 1995 Apr; 114(2):147-55. PubMed ID: 7605383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of antioxidant/anti-inflammatory properties and apoA-I-containing subpopulations of HDL from family subjects with monogenic low HDL disorders.
    Daniil G; Phedonos AA; Holleboom AG; Motazacker MM; Argyri L; Kuivenhoven JA; Chroni A
    Clin Chim Acta; 2011 Jun; 412(13-14):1213-20. PubMed ID: 21420943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant LCAT (Lecithin:Cholesterol Acyltransferase) Rescues Defective HDL (High-Density Lipoprotein)-Mediated Endothelial Protection in Acute Coronary Syndrome.
    Ossoli A; Simonelli S; Varrenti M; Morici N; Oliva F; Stucchi M; Gomaraschi M; Strazzella A; Arnaboldi L; Thomas MJ; Sorci-Thomas MG; Corsini A; Veglia F; Franceschini G; Karathanasis SK; Calabresi L
    Arterioscler Thromb Vasc Biol; 2019 May; 39(5):915-924. PubMed ID: 30894011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT.
    Forte TM; Bielicki JK; Goth-Goldstein R; Selmek J; McCall MR
    J Lipid Res; 1995 Jan; 36(1):148-57. PubMed ID: 7706940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lecithin:cholesterol acyltransferase-induced transformation of HepG2 lipoproteins.
    McCall MR; Nichols AV; Blanche PJ; Shore VG; Forte TM
    J Lipid Res; 1989 Oct; 30(10):1579-89. PubMed ID: 2515238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flipped C-Terminal Ends of APOA1 Promote ABCA1-Dependent Cholesterol Efflux by Small HDLs.
    He Y; Pavanello C; Hutchins PM; Tang C; Pourmousa M; Vaisar T; Song HD; Pastor RW; Remaley AT; Goldberg IJ; Costacou T; Sean Davidson W; Bornfeldt KE; Calabresi L; Segrest JP; Heinecke JW
    Circulation; 2024 Mar; 149(10):774-787. PubMed ID: 38018436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse cholesterol transport in plasma of patients with different forms of familial HDL deficiency.
    von Eckardstein A; Huang Y; Wu S; Funke H; Noseda G; Assmann G
    Arterioscler Thromb Vasc Biol; 1995 May; 15(5):691-703. PubMed ID: 7749883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-free apolipoproteins A-I and A-II promote remodeling of reconstituted high density lipoproteins and alter their reactivity with lecithin:cholesterol acyltransferase.
    Durbin DM; Jonas A
    J Lipid Res; 1999 Dec; 40(12):2293-302. PubMed ID: 10588955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of subspecies of lipoprotein containing apolipoprotein A-I on cholesterol efflux from cholesterol-loaded macrophages: functional correlation with lecithin: cholesterol acyltransferase.
    Ohta T; Nakamura R; Ikeda Y; Shinohara M; Miyazaki A; Horiuchi S; Matsuda I
    Biochim Biophys Acta; 1992 Nov; 1165(1):119-28. PubMed ID: 1420341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.